keyword
https://read.qxmd.com/read/38276098/transcatheter-aortic-valve-implantation-to-treat-degenerated-aortic-mitral-and-tricuspid-bioprosthesis
#21
REVIEW
Arif A Khokhar, Jonathan Curio, Alessandro Sticchi, Adam Hartley, Ozan M Demir, Neil Ruparelia
Transcatheter aortic valve implantation (TAVI) is now well established as the treatment of choice for patients with native aortic valve stenosis who are high or intermediate risk for surgical aortic valve replacement. Recent data has also supported the use of TAVI in patients at low surgical risk and also in anatomical subsets that were previously felt to be contra-indicated including bicuspid aortic valves and aortic regurgitation. With advancements and refinements in procedural techniques, the application of this technology has now been further expanded to include the management of degenerated bioprosthesis...
January 19, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38245394/clinical-outcomes-following-transcatheter-mitral-valve-in-valve-replacement-using-a-meril-myval-transcatheter-heart-valve
#22
JOURNAL ARTICLE
Mullasari Ajit Sankardas, Vijayakumar Subban, Sivakumar Kothandam, Aashish Chopra, Latchumanadhas Kalidoss, Kalaichelvan Udhayakumar, Ramkumar Sollimuthu, Kumar Chidambaram, Harini Anandan, Ravinder Singh Rao
AIM: Transcatheter mitral valve-in-valve (TMViV) replacement for degenerated surgically implanted bioprosthetic valves has been described by both transseptal and transapical approaches. The balloon-expandable Myval transcatheter valve (Meril Life Science, Vapi, India) is commonly used for transcatheter valve-in-valve procedures in India. This study aimed to report in-hospital, 30-day, and 1-year outcomes of Myval patients who underwent TMViV in a single tertiary care centre in India. METHODS: Symptomatic patients with surgical bioprosthetic mitral valve failure with New York Heart Association (NYHA) class III-IV symptoms, despite optimal medical therapy and high or very high risk for redo surgery, were assigned to TMViV following heart team discussions...
January 19, 2024: Heart, Lung & Circulation
https://read.qxmd.com/read/38222260/assessing-potential-risks-of-future-redo-transcatheter-aortic-valve-replacement-in-asian-patients
#23
JOURNAL ARTICLE
Norihisa Miyawaki, Kenichi Ishizu, Shinichi Shirai, Kenji Nakano, Tadatomo Fukushima, Euihong Ko, Yasuo Tsuru, Hiroaki Tashiro, Miho Nakamura, Hiroyuki Tabata, Toru Morofuji, Takashi Morinaga, Masaomi Hayashi, Akihiro Isotani, Nobuhisa Ohno, Shinichi Kakumoto, Kenji Ando
BACKGROUND: In the Asian cohort, data are limited on the risk for coronary obstruction due to sinus of Valsalva (SOV) sequestration in redo transcatheter aortic valve replacement (TAVR) procedures. OBJECTIVES: The aim of this study was to assess the potential risk for coronary obstruction in simulated redo TAVR in Asian patients. METHODS: Post-TAVR computed tomographic data from 788 patients who received balloon-expandable (BE) SAPIEN 3 transcatheter aortic valves (TAVs) and 334 patients who received self-expanding (SE) Evolut R or Evolut PRO TAVs were analyzed...
January 2024: JACC Asia
https://read.qxmd.com/read/38204664/true-redo-aortic-root-replacement-versus-root-replacement-after-any-previous-surgery
#24
JOURNAL ARTICLE
Parth M Patel, Dov Levine, Andy Dong, Tsuyoshi Yamabe, Jane Wei, Jose Binongo, Bradley G Leshnower, Hiroo Takayama, Edward P Chen
OBJECTIVE: The impact of previous aortic root replacement (True-Redo) versus any previous operation (Any-Redo) on outcomes after reoperative aortic root replacement (redo-ROOT) is largely unknown. In this first multi-institutional study, the clinical impact True-Redo versus Any-Redo in the setting of redo-ROOT was reviewed. METHODS: From 2004 to 2021, 822 patients underwent redo-ROOT at 2 major academic centers: 638 Any-Redo and 184 True-Redo. Matching based on preoperative demographics and concomitant operations resulted in 174 matched pairs...
December 2023: JTCVS open
https://read.qxmd.com/read/38204648/redo-aortic-surgery-does-one-versus-multiple-affect-outcomes
#25
JOURNAL ARTICLE
Elizabeth L Norton, Kanika Kalra, Bradley G Leshnower, Jane W Wei, Jose N Binongo, Edward P Chen
OBJECTIVE: Redo aortic surgery has a higher risk of morbidity and mortality because it is technically complex due to mediastinal adhesions, infection, and previously implanted prostheses. In this study, we sought to benchmark our single-center experience comparing outcomes in patients undergoing aortic surgery after 1 versus multiple previous cardiac operations. METHODS: Between 2004 and 2019, 429 patients underwent redo aortic surgery. They were classified as aortic surgery after 1 previous surgery (first redo surgery, n = 360) and aortic surgery after 2 or more (multiple) previous surgeries (multiple redo surgery, n = 69)...
December 2023: JTCVS open
https://read.qxmd.com/read/38204550/first-in-human-treatment-of-severe%C3%A2-tricuspid-regurgitation-using-a-novel%C3%A2-cross-caval-heterotopic-device
#26
JOURNAL ARTICLE
Antonio Sisinni, Rodrigo Estévez-Loureiro, Berenice Caneiro-Queija, Manuel Barreiro-Pérez, Jose A Baz, Pablo Pazos, Rocio Gonzalez-Ferreiro, Andrés Iñiguez-Romo
A 79-year-old woman, previously surgically treated for mitral and aortic valve replacement, experienced recurrent torrential tricuspid regurgitation after 2 transcatheter edge-to-edge repair procedures. Heart team assessment deemed the patient high risk for redo surgery and excluded transcatheter edge-to-edge repair and orthotopic replacement. The patient was then scheduled for a novel cross-caval device implantation.
December 20, 2023: JACC. Case reports
https://read.qxmd.com/read/38202277/early-and-mid-term-outcomes-of-using-the-chimney-technique-in-redo-mitral-valve-replacement-in-patients-with-a-small-mitral-annulus
#27
JOURNAL ARTICLE
Mingyuan Yang, Laichun Song, Yong Xiao, Liang Tao
The outcomes of redo mitral valve replacement (Re-MVR) in a small mitral annulus with the use of the chimney technique are not well documented. The purpose of this study is to present our early experience with this group of patients, illustrating the periop-erative complications and mortality outcomes. From 2019 to 2020, 77 consecutive patients underwent Re-MVR with the use of the chimney technique because of a small mitral annulus. To evaluate heart structural integrity and clinical outcomes, postoperative clinical data and echocardiograms were examined...
January 3, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38199710/what-do-we-really-know-about-transcatheter-mitral-valve-in-valve-procedures
#28
EDITORIAL
Matthew W Sherwood, Amit N Vora
No abstract text is available yet for this article.
January 16, 2024: Journal of the American College of Cardiology
https://read.qxmd.com/read/38196481/a-case-of-stuck-mechanical-tricuspid-valve
#29
Abdul Nasir, Mujeeb Ur Rehman, Salman Khan, Hamza Ali
A 34-year-old non hypertensive, non-diabetic and ill looking weak woman came to our emergency department with shortness of breath NYHA III-IV, severe bilateral pedal edema extending up to the thighs and gross ascites. Physical examination revealed 3mm pitting ankle and leg edema and hemodynamically was stable with raised jugular venous pressure. There was a closing and opening mechanical click on Cardiac auscultation. At the lower left sternal border, there was grade 2/6 holodiastolic rumble and a grade 2/6 systolic murmur...
2024: Pakistan Journal of Medical Sciences Quarterly
https://read.qxmd.com/read/38180849/modified-commando-procedure-using-a-double-valve-composite-through-an-aorto-annulo-septotomy
#30
JOURNAL ARTICLE
Kanji Matsuzaki, Kisato Mitomi, Akito Imai, Masataka Sato, Yasunori Watanabe
Double valve replacement of aortic and mitral valves with intervalvular fibrous body reconstruction (Commando procedure) is a challenging operation. Particularly in redo surgery for prosthetic valve endocarditis, special techniques are needed for approaching and reconstructing the valve complex. We performed a modified Commando procedure using a double valve composite through an aorto-annulo-septotomy. This approach provided a good field of vision at the combined aortic and mitral annulus without incising the left atrial roof...
January 5, 2024: Interdiscip Cardiovasc Thorac Surg
https://read.qxmd.com/read/38172707/sutureless-biological-aortic-valve-replacement-su-avr-in-redo-operations-a-retrospective-real-world-experience-report-of-clinical-and-echocardiographic-outcomes
#31
JOURNAL ARTICLE
Ian Cummings, M Yousuf Salmasi, Halil Ibrahim Bulut, Alicja Zientara, Mahmoud AlShiekh, George Asimakopoulos
OBJECTIVE: This retrospective study aimed to compare the outcomes of sutureless aortic valve replacement (su-AVR) and conventional bioprosthetic sutured AVR (cAVR) in high-risk patients undergoing redo surgery. METHODS: A total of 79 patients who underwent redo AVR between 2014 and 2021 were included in the study. Of these, 27 patients underwent su-AVR and 52 underwent cAVR. Patient characteristics and clinical outcomes were analysed using multivariate regression and Kaplan Meier survival test...
January 3, 2024: BMC Cardiovascular Disorders
https://read.qxmd.com/read/38155981/redo-aortic-root-surgery-post-ross-procedure
#32
JOURNAL ARTICLE
Alexander Bogachev-Prokophiev, Ravil Sharifulin, Igor Demin, Anastasiia Karadzha, Sergey Zheleznev, Alexander Karaskov, Alexander Afanasyev, Alexey Pivkin, Mikhail Ovcharov, Anton Zalesov, Ivan Murashov, Bashir Tsaroev, Alexander Chernyavsky
BACKGROUND: Despite numerous advantages of the Ross procedure, it presents a risk of late autograft and right ventricular outflow tract conduit failure. This study aimed to analyze the outcomes of autograft dysfunction reoperations using autograft-sparing and root replacement techniques. METHODS: Between 2015 and 2023, 49 patients underwent redo root surgery in our institution. Autograft valve-sparing procedures (VSP) were performed in 20 cases and the Bentall procedure (BP) in 29 patients...
2023: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38130866/veno-arterial-extracorporeal-membrane-oxygenation-as-a-perioperative-support-to-redo-cardiac-surgery-for-inoperable-adult-patients-a-case-series
#33
Alvaro Diego Peña, Alejandro Moreno-Angarita, Mayra Estacio, Diego Fernando Bautista, Ivan Fernando Quintero, Stephany Olaya, Eduardo Alberto Cadavid
BACKGROUND: The present article describes three cases of patients in cardiogenic shock (CS) with previous cardiac surgery that made them initially inoperable. Perioperative support with veno-arterial extracorporeal membrane oxygenation (VA-ECMO) improved haemodynamic status and results in these high-risk patients. CASE SUMMARY: Case 1 is a 57-year-old male morbidly obese with previous aortic valve replacement (AVR) who presented with chest pain and developed cardiac arrest...
December 2023: European Heart Journal. Case Reports
https://read.qxmd.com/read/38127022/pulmonary-valve-replacement-in%C3%A2-tetralogy-of-fallot-procedural-volume-and-durability-of-bioprosthetic-pulmonary%C3%A2-valves
#34
JOURNAL ARTICLE
Mathis Gröning, Morten Holdgaard Smerup, Kim Munk, Helle Andersen, Dorte Guldbrand Nielsen, Henrik Nissen, Ulrik Markus Mortensen, Annette Schophuus Jensen, Pernille Steen Bække, Jesper Bjerre, Morten Engholm, Niels Vejlstrup, Klaus Juul, Eva Vad Søndergaard, Hans Gustav Hørsted Thyregod, Henrik Ørbæk Andersen, Morten Helvind, Ole De Backer, Christian Jøns, Michael Rahbek Schmidt, Troels Højsgaard Jørgensen, Lars Sondergaard
BACKGROUND: Robust data on changes in pulmonary valve replacement (PVR) procedural volume and predictors of bioprosthetic pulmonary valve (BPV) durability in patients with tetralogy of Fallot (TOF) are scarce. OBJECTIVES: This study sought to assess temporal trends in PVR procedural volume and BPV durability in a nationwide, retrospective TOF cohort. METHODS: Data were obtained from patient records. Robust linear regression was used to assess temporal trends in PVR procedural volume...
November 29, 2023: JACC. Cardiovascular Interventions
https://read.qxmd.com/read/38104756/myocardial-injury-after-transcatheter-mitral-valve-replacement-versus-surgical-reoperation
#35
JOURNAL ARTICLE
Mauricio Felippi de Sá Marchi, Vitor Emer Egypto Rosa, Pedro Felipe Gomes Nicz, José Honório de Almeida Palma da Fonseca, Pedro Calomeni, Fernando Chiodini, Roney Orismar Sampaio, Pablo Maria Alberto Pomerantzeff, Marcelo de Campos Vieira, Flávio Tarasoutchi, Nicolas M Van Mieghem, Fábio Sandoli de Brito, Alexandre Abizaid, Henrique Barbosa Ribeiro
This study aimed to evaluate the incidence and clinical implications of myocardial injury, as determined by cardiac biomarker elevation, among patients undergoing mitral bioprosthesis dysfunction treatment with transcatheter mitral valve replacement (TMVR) vs. surgical mitral valve replacement reoperation (SMVR-REDO). Between 2014 and 2023, 310 patients with mitral bioprosthesis failure were included (90 and 220 patients for TMVR and SMVR-REDO, respectively). Multivariable analysis and propensity score matching were performed to adjust for the intergroup differences in baseline characteristics...
December 15, 2023: American Journal of Cardiology
https://read.qxmd.com/read/38099636/fifth-time-redo-mitral-valve-replacement-via-right-thoracotomy-under-systemic-hyperkalemia-cardiopulmonary-bypass-without-aortic-cross-clamp
#36
Tomohisa Takeichi, Yoshihisa Morimoto, Akitoshi Yamada, Takanori Tanaka
The surgical management of prosthetic valvular endocarditis (PVE) can be challenging. We report a case of a 46-year-old female patient who had a history of four cardiac operations. We chose a mitral valve replacement via right thoracotomy to enable optimal exposure of the mitral valve (MV). Because of multi-reoperations, we employed systemic hyperkalemia for cardiac arrest to protect the heart during cardiopulmonary bypass (CPB) without aortic cross-clamping. Here, we present a complex operation that performed management of CPB under hyperkalemia and the patient had a good postoperative recovery...
December 2023: Journal of Extra-corporeal Technology
https://read.qxmd.com/read/38093824/emergent-percutaneous-closure-of-sub-annular-aortic-root-pseudoaneurysm-in-the-setting-of-composite-graft-dehiscence-a-case-report
#37
Samuel Stephenson, Michael Gambill, Matthew Summers
BACKGROUND: Aortic conduit pseudoaneurysms are rare complications of surgical aortic root replacements. These complications are typically treated with a redo-sternotomy, but these surgeries carry high mortality rates, and patients may not always be good surgical candidates. There have been a few reported cases where aortic pseudoaneurysms have been successfully treated percutaneously with both short- and long-term success. We describe a case were a sub-annular aortic root pseudoaneurysm was closed using an Amplatzer Vascular Plug 2 device...
December 2023: European Heart Journal. Case Reports
https://read.qxmd.com/read/38078413/long-term-prognosis-in-patients-undergoing-redo-isolated-aortic-valve-replacement
#38
JOURNAL ARTICLE
Aleksander Dokollari, Gianluca Torregrossa, Serge Sicouri, Matteo Cameli, Giulia Elena Mandoli, Stephanie Kjelstrom, Edvin Prifti, Altin Veshti, Massimo Bonacchi, Sandro Gelsomino
Aim: To evaluate clinical outcomes after redo aortic valve replacement (AVR) with sutured valves, versus valve-in-valve transcatheter aortic valve replacement (ViV-TAVR), versus sutureless valves. Methods: We identified 113 consecutive patients undergoing redo AVR with either ViV-TAVR, redo-sutured and redo-sutureless valves between August 2010 to March 2020. Heart-team made the decision whether patient should undergo redo-sutureless versus ViV-TAVR, versus redo-sutured AVR. Results: Preoperatively, redo-sutured (n = 57), ViV-TAVR (n = 31) and redo-sutureless (n = 25) patients were compared...
December 11, 2023: Future Cardiology
https://read.qxmd.com/read/38074020/redo-mitral-valve-replacement-after-valve-in-valve-transcatheter-mitral-valve-replacement
#39
Yusuke Tsukioka, Valluvan Jeevanandam
The rising preference for percutaneous mitral valve-in-valve replacement (ViV TMVR) over redo surgical mitral valve replacement (MVR) is primarily due to its reduced bleeding risk. This report details a bloodless redo MVR performed for mitral stenosis post-ViV TMVR. We present detailed intraoperative findings, including images of the extracted bioprosthetic valves and cardiac anatomy, providing valuable insights into the surgical complexities encountered. The case underscores the importance of meticulous planning and execution in redo MVR, especially in patients with a history of multiple valve interventions...
November 2023: Curēus
https://read.qxmd.com/read/38072363/degenerated-transcatheter-aortic-valve-replacement-investigation-and-management-options
#40
REVIEW
Sarah Mauler-Wittwer, Georgios Giannakopoulos, Marc Arcens, Stephane Noble
With the expansion of transcatheter aortic valve replacement (TAVR) to younger and lower surgical-risk patients, many younger and less co-morbid patients will be treated with TAVR and are expected to have a life expectancy that will exceed the durability of their transcatheter heart valve. Consequently, the number of patients requiring re-intervention will undoubtedly increase in the near future. Redo-TAVR and TAVR explant followed by surgical aortic valve replacement are the different therapeutic options in the event of bioprosthetic valve failure and the need for re-intervention...
December 8, 2023: Canadian Journal of Cardiology
keyword
keyword
14853
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.